NCT06366269

Brief Summary

The goal of this clinical trial is to learn if acupuncture in addition to behavioral changes can better treat in women with bladder pain syndrome (also known as interstitial cystitis) that have not received other treatments. The main question it aims to answer is: Does acupuncture improve pain symptoms on the Interstitial Cystitis Index? Researchers will compare six (6) weeks behavioral management alone to behavioral management and acupuncture. Participants will

  • complete surveys about their bladder pain symptoms
  • make behavioral changes that have been shown to improve bladder pain symptoms
  • attend six (6) weekly acupuncture sessions
  • attend six (6) weekly physical therapy sessions after finishing acupuncture

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
5mo left

Started Jan 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress76%
Jan 2025Oct 2026

First Submitted

Initial submission to the registry

April 10, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 15, 2024

Completed
9 months until next milestone

Study Start

First participant enrolled

January 21, 2025

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2026

Last Updated

January 8, 2026

Status Verified

January 1, 2026

Enrollment Period

1.7 years

First QC Date

April 10, 2024

Last Update Submit

January 6, 2026

Conditions

Keywords

acupuncturebladder pain syndromeinterstitial cystitis

Outcome Measures

Primary Outcomes (1)

  • O'Leary-Sant Interstitial Cystitis Index (OLSICI)

    Validated 8-item questionnaire with reported scores ranging 0-37. Higher scores are consistent with worse symptoms.

    Baseline, every 2 weeks x3 (6 week study protocol period), every 4 weeks x 13 (52 week post-treatment period)

Secondary Outcomes (5)

  • Patient Global Impression of Improvement (PGI-I)

    x1 (end of 6 week study protocol period), x1 (end of 1 year post-treatment period)

  • Short Form (SF-36)

    x1 (end of 6 week study protocol period), x1 (end of 1 year post-treatment period)

  • Genitourinary Pain Index (GUPI)

    Baseline, every 2 weeks x3 (6 week study protocol period), every 4 weeks x 13 (52 week post-treatment period)

  • Number of additional treatments used during study period

    1 year post-treatment period

  • Number of unscheduled interactions

    1 year post-treatment period

Study Arms (2)

Acupuncture

EXPERIMENTAL

Participants will receive instruction (verbal and written) on recommended changes to diet and urinary habits to treat bladder pain. They will complete six (6) weekly one hour acupuncture sessions followed by pelvic floor physical therapy.

Other: AcupunctureBehavioral: Behavioral managementOther: Physical therapy

Behavioral Management

ACTIVE COMPARATOR

Participants will receive instruction (verbal and written) on recommended changes to diet and urinary habits to treat bladder pain for six (6) weeks before starting pelvic floor physical therapy.

Behavioral: Behavioral managementOther: Physical therapy

Interventions

traditional and electroacupuncture

Acupuncture

based on American urologic association guidelines

AcupunctureBehavioral Management

pelvic floor with biofeedback

AcupunctureBehavioral Management

Eligibility Criteria

Age18 Years - 89 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Meets American Urologic Association (AUA) criteria for interstitial cystitis/bladder pain syndrome (IC/BPS): "An unpleasant sensation (pain, pressure, discomfort) perceived to be related to the urinary bladder, associated with lower urinary tract symptoms of more than 6 weeks duration, in the absence of other identifiable cause"
  • Negative urine culture
  • Has completed cystoscopic evaluation for IC/BPS

You may not qualify if:

  • History of recurrent urinary tract infection (2 or more culture-positive in 6 months or 3 or more in 12 months)
  • History of overactive bladder
  • History of bleeding disorder or are currently on chronic anti-coagulation
  • Post-void residual \>100mL
  • Has previously undergone any of the following treatments for any indication: acupuncture, pelvic floor physical therapy, pre-tibial nerve stimulation (PTNS), sacral neuromodulation, or intradetrusor Botox
  • Prior bladder augmentation
  • Currently undergoing or will undergo treatment for a urologic or gynecologic malignancy
  • Currently pregnant (if applicable, based on self-report)
  • Implanted pacemaker or defibrillator (AICD) or any metallic implants below umbilicus (eg hip or knee replacements)
  • Non-English speaking and reading

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospitals

Cleveland, Ohio, 44106, United States

RECRUITING

MeSH Terms

Conditions

Cystitis, Interstitial

Interventions

Acupuncture TherapyPhysical Therapy Modalities

Condition Hierarchy (Ancestors)

CystitisUrinary Bladder DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeuticsRehabilitation

Study Officials

  • David Sheyn, MD

    University Hospitals Cleveland Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, INVESTIGATOR
Masking Details
Group allocation will be masked to the care provider and investigators only while participants undergo the initial 6 weeks of treatment. Due to the nature of the intervention (acupuncture) participants are not able to be blinded.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physician, UHMG

Study Record Dates

First Submitted

April 10, 2024

First Posted

April 15, 2024

Study Start

January 21, 2025

Primary Completion (Estimated)

October 1, 2026

Study Completion (Estimated)

October 1, 2026

Last Updated

January 8, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations